Skip to main content

Table 2 Associations between Plasmodium infection status and being seropositive for antibodies to P. falciparum antigens

From: Acquisition of antibodies to Plasmodium falciparum and Plasmodium vivax antigens in pregnant women living in a low malaria transmission area of Brazil

Antigen

Infected (%)

(n = 207)

Uninfected (%) (n = 201)

AOR (95% CI)

P-value

CS2VSA

14.0

4.0

4.1 (1.8, 9.1)

0.001

3D7VSA

7.3

6.5

1.2 (0.6, 2.6)

0.59

CS2 Phago

18.4

17.0

1.1 (0.7, 1.9)

0.69

3D7 Phago

14.0

13.0

1.1 (0.6, 1.9)

0.78

E8B Phago

60.9

42.8

2.1 (1.4, 3.1)

< 0.0001

DBL1-7G8

46.4

44.3

1.1 (0.74, 1.62)

0.65

DBL2-isolate

46.9

47.8

0.96 (.65, 1.42)

0.84

DBL2 (ID1-ID2)-FCR3

34.9

31.3

1.2 (.77, 1.77)

0.47

DBL3-FCR3

29.1

30.4

0.92 (0.60, 1.41)

0.71

DBL3-7G8

54.6

49.8

1.22 (0.83, 1.81)

0.30

DBL4-FCR3

34.8

32.8

1.08 (0.72, 1.64)

0.69

DBL4-isolate

61.8

56.7

1.24 (0.83, 1.84)

0.29

DBL5-isolate

42.5

39.8

1.1 (.74, 1.63)

0.65

DBL5-3D7

67.2

60.2

1.33 (0.89, 2.00)

0.17

DBL6-IT4

25.6

20.9

1.32 (0.83, 2.10)

0.24

Schizont

88.9

45.3

9.7 (5.8, 16.3)

< 0.0001

PfMSP1-19

91.8

44.3

12.9 (7.4, 22.4)

< 0.0001

  1. Data presented as seropositivity percentage and odds ratio (95% confidence interval); Multivariate logistic regression analysis was performed to determine the effect of malaria infection on the antibody seropositivity in pregnant women with Plasmodium infection (P. falciparum only or both P. falciparum and P. vivax infections) and without Plasmodium infection. Analysis was adjusted for gravidity, body mass index at enrolment, and maternal age enrollment. AOR, Adjusted odds ratio; 95% CI, 95% confidence interval; Pf, P. falciparum; VSA, variant surface antigens; DBL, Duffy binding like; MSP, merozoite surface protein. P values that were less than 0.05 were indicated in bold